These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 24007881

  • 1. IL-10 restrains IL-17 to limit lung pathology characteristics following pulmonary infection with Francisella tularensis live vaccine strain.
    Slight SR, Monin L, Gopal R, Avery L, Davis M, Cleveland H, Oury TD, Rangel-Moreno J, Khader SA.
    Am J Pathol; 2013 Nov; 183(5):1397-1404. PubMed ID: 24007881
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
    Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW.
    Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
    [Abstract] [Full Text] [Related]

  • 3. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD, Singh R, Metzger DW.
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.
    Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, Guglani L, Alcorn JF, Strawbridge H, Park SM, Onishi R, Nyugen N, Walter MJ, Pociask D, Randall TD, Gaffen SL, Iwakura Y, Kolls JK, Khader SA.
    Immunity; 2009 Nov 20; 31(5):799-810. PubMed ID: 19853481
    [Abstract] [Full Text] [Related]

  • 5. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
    Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW.
    Vaccine; 2008 Sep 26; 26(41):5276-88. PubMed ID: 18692537
    [Abstract] [Full Text] [Related]

  • 6. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.
    Roberts LM, Davies JS, Sempowski GD, Frelinger JA.
    Vaccine; 2014 Jun 17; 32(29):3595-603. PubMed ID: 24837506
    [Abstract] [Full Text] [Related]

  • 7. Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection.
    Metzger DW, Salmon SL, Kirimanjeswara G.
    Infect Immun; 2013 Jun 17; 81(6):2022-7. PubMed ID: 23529615
    [Abstract] [Full Text] [Related]

  • 8. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
    Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS.
    PLoS One; 2013 Jun 17; 8(4):e61539. PubMed ID: 23613871
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis.
    Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW.
    J Immunol; 2007 Jul 01; 179(1):532-9. PubMed ID: 17579074
    [Abstract] [Full Text] [Related]

  • 10. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R, Harris G, Conlan JW, Chen W.
    Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863
    [Abstract] [Full Text] [Related]

  • 11. A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.
    Ashtekar AR, Katz J, Xu Q, Michalek SM.
    PLoS One; 2012 May 10; 7(11):e50460. PubMed ID: 23209745
    [Abstract] [Full Text] [Related]

  • 12. Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity.
    Singh A, Rahman T, Malik M, Hickey AJ, Leifer CA, Hazlett KR, Sellati TJ.
    PLoS One; 2013 May 10; 8(3):e58513. PubMed ID: 23554897
    [Abstract] [Full Text] [Related]

  • 13. Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4.
    Ketavarapu JM, Rodriguez AR, Yu JJ, Cong Y, Murthy AK, Forsthuber TG, Guentzel MN, Klose KE, Berton MT, Arulanandam BP.
    Proc Natl Acad Sci U S A; 2008 Jul 08; 105(27):9313-8. PubMed ID: 18591675
    [Abstract] [Full Text] [Related]

  • 14. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.
    Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    PLoS One; 2010 Oct 12; 5(10):e13349. PubMed ID: 20967278
    [Abstract] [Full Text] [Related]

  • 15. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL.
    J Immunol; 2010 May 15; 184(10):5791-801. PubMed ID: 20393138
    [Abstract] [Full Text] [Related]

  • 16. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response.
    Barrigan LM, Tuladhar S, Brunton JC, Woolard MD, Chen CJ, Saini D, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA.
    Infect Immun; 2013 Jun 15; 81(6):2028-42. PubMed ID: 23529616
    [Abstract] [Full Text] [Related]

  • 17. Vaccine-Mediated Mechanisms Controlling Replication of Francisella tularensis in Human Peripheral Blood Mononuclear Cells Using a Co-culture System.
    Eneslätt K, Golovliov I, Rydén P, Sjöstedt A.
    Front Cell Infect Microbiol; 2018 Jun 15; 8():27. PubMed ID: 29468144
    [Abstract] [Full Text] [Related]

  • 18. Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia.
    Lu Z, Madico G, Roche MI, Wang Q, Hui JH, Perkins HM, Zaia J, Costello CE, Sharon J.
    Immunology; 2012 Jul 15; 136(3):352-60. PubMed ID: 22486311
    [Abstract] [Full Text] [Related]

  • 19. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W.
    Vaccine; 2005 Mar 31; 23(19):2477-85. PubMed ID: 15752834
    [Abstract] [Full Text] [Related]

  • 20. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
    Hickey AJ, Hazlett KR, Kirimanjeswara GS, Metzger DW.
    Vaccine; 2011 Sep 16; 29(40):6941-7. PubMed ID: 21803089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.